Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

Presentation TCT 2024

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

Presenter: TsungYing Tsai

October 30, 2024

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

Presentation TCT 2024

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

Presenter: Francesca Maria Di Muro

October 29, 2024

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

Presentation TCT 2024

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

Presenter: Dipti Itchhaporia

October 29, 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presentation TCT 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presenter: Woo Jin Ahn

October 29, 2024

Lipoprotein(a): The New Kid on the Block

Presentation Complex Coronary Cases 2023

Lipoprotein(a): The New Kid on the Block

Presenter: Pam R. Taub

June 15, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.